Get the Stockscreener App
2.11
6.22%
-0.14
After Hours:
2.11
Abvc Biopharma Inc stock is traded at $2.11, with a volume of 110.48K.
It is down -6.22% in the last 24 hours and down -29.43% over the past month.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$2.25
Open:
$2.25
24h Volume:
110.48K
Relative Volume:
1.39
Market Cap:
$51.28M
Revenue:
$152.40K
Net Income/Loss:
$-10.52M
P/E Ratio:
-0.8463
EPS:
-2.4931
Net Cash Flow:
$-4.26M
1W Performance:
-12.45%
1M Performance:
-29.43%
6M Performance:
+14.05%
1Y Performance:
+309.71%
1-Day Range:
$2.085
$2.26
1-Week Range:
$2.06
$2.4972
52-Week Range:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Name
Abvc Biopharma Inc
Sector
Industry
Phone
510-668-0881
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
2.11 | 54.68M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abvc Biopharma Inc Stock (ABVC) Latest News
Analyzing ABVC BioPharma (NASDAQ:ABVC) & Oculis (NASDAQ:OCS) - Defense World
Head-To-Head Analysis: ABVC BioPharma (NASDAQ:ABVC) & Northwest Biotherapeutics (OTCMKTS:NWBO) - Defense World
Can ABVC BioPharma Inc. stock beat market expectations this quarterEarnings Growth Report & Trade Opportunity Analysis Reports - Newser
ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States - TradingView
What analyst consensus says on ABVC BioPharma Inc. stockJuly 2025 Price Swings & AI Powered Market Trend Analysis - Newser
What margin trends mean for ABVC BioPharma Inc. stockPortfolio Value Summary & Long-Term Growth Plans - Newser
ABVC BioPharma Highlights Strengthened Operations at BioKey's 28,176-sq.-ft. Silicon Valley Facility, Featuring U.S.-Based Multi-Product Capabilities Including Functional Foods, and Expansion Outlook Supporting Up to [1,000] Jobs by 2030 - TradingView
ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received - Yahoo Finance
Is ABVC BioPharma Inc. stock cheap compared to fundamentals2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Can ABVC BioPharma Inc. rally from current levelsInsider Selling & Precise Buy Zone Tips - newser.com
How geopolitical tensions affect ABVC BioPharma Inc. stockSell Signal & AI Enhanced Trading Signals - newser.com
Will earnings trigger a reversal in ABVC BioPharma Inc.Trend Reversal & AI Forecast Swing Trade Picks - newser.com
Will ABVC BioPharma Inc. price bounce be sustainableSell Signal & AI Enhanced Trade Execution Alerts - newser.com
How to use a screener to detect ABVC BioPharma Inc. breakoutsTake Profit & Verified Swing Trading Watchlist - newser.com
How ABVC BioPharma Inc. stock benefits from strong dollarTake Profit & Long-Term Capital Growth Strategies - newser.com
ABVC BioPharma Inc. recovery potential after sell off2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies - MSN
Is ABVC BioPharma Inc. stock cheap at current valuationBreakout Watch & Free Growth Oriented Trading Recommendations - newser.com
ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million - Yahoo Finance
Building trade automation scripts for ABVC BioPharma Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
Real time pattern detection on ABVC BioPharma Inc. stock2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Key resistance and support levels for ABVC BioPharma Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
[424B4] ABVC BIOPHARMA, INC. Prospectus Filed Pursuant to Rule 424(b)(4) - Stock Titan
What analysts say about ABVC BioPharma Inc stockTechnology Stock Trends & Predict Volatility With Our Neural Network - earlytimes.in
Why analysts upgrade ABVC BioPharma Inc. stockMarket Performance Report & Verified Stock Trade Ideas - newser.com
Automated trading signals detected on ABVC BioPharma Inc.Breakout Watch & Step-by-Step Swing Trade Plans - newser.com
How ABVC BioPharma Inc. stock trades before earningsQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Will ABVC BioPharma Inc. stock sustain high P E ratios2025 Price Action Summary & Risk Controlled Daily Trade Plans - newser.com
Abvc Biopharma Inc Stock (ABVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):